financetom
Business
financetom
/
Business
/
--Exxon Pleads Not Guilty to Misstating Equipment Value in Guyana Court, Bloomberg Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Exxon Pleads Not Guilty to Misstating Equipment Value in Guyana Court, Bloomberg Says
May 10, 2024 9:43 AM

12:21 PM EDT, 05/10/2024 (MT Newswires) --

Price: 117.94, Change: -0.50, Percent Change: -0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Alpayana Commences All-Cash Offer To Acquire Sierra Metals
BRIEF-Alpayana Commences All-Cash Offer To Acquire Sierra Metals
Dec 30, 2024
Dec 30 (Reuters) - * ALPAYANA COMMENCES ALL-CASH OFFER TO ACQUIRE SIERRA METALS INC. * ALPAYANA S.A.C.: UNDER DEAL, SIERRA SHAREHOLDERS WHO TENDER COMMON SHARES TO GET C$0.85 IN CASH FOR EACH COMMON SHARE Source text: ...
Pennsylvania governor complains to regulator about PJM's power market rules
Pennsylvania governor complains to regulator about PJM's power market rules
Dec 30, 2024
NEW YORK (Reuters) - Pennsylvania Governor Josh Shapiro filed a complaint with a federal energy regulator against PJM Interconnection on Monday, arguing that the largest U.S. power grid operator must change its market rules or risk soaring electricity costs. PJM Interconnection, which runs the electrical grid covering more than 65 million Americans across parts of 13 states from Illinois to...
Elon Musk wants weak Europe, says Germany's vice chancellor
Elon Musk wants weak Europe, says Germany's vice chancellor
Dec 30, 2024
BERLIN, Dec 31 (Reuters) - U.S. billionaire Elon Musk's support for Germany's far-right Alternative for Germany (AfD) is a logical and systematic play for a weak Europe that will not be able to regulate as strongly, Vice Chancellor Robert Habeck said in his New Year's address. The calls by Musk are not made out of ignorance, said Habeck, who is...
ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial
ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial
Dec 30, 2024
06:02 PM EST, 12/30/2024 (MT Newswires) -- ADC Therapeutics ( ADCT ) said late Monday it has completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. We anticipate sharing topline results of the primary endpoint analysis by the end of 2025 once the pre-specified...
Copyright 2023-2026 - www.financetom.com All Rights Reserved